Speaker Profile

M.D., VP of Medical Affairs & Clinical Development, Karius

Dr. Hong joined Karius after 14 years at Stanford University, where he was Clinical Assistant Professor of Pediatric Infectious Diseases. He also served as chief of pediatric infectious diseases at the Stanford-affiliated Santa Clara Valley Medical Center. His prior studies in respiratory virus infections in children focused on host–pathogen interactions and novel adjuvants for respiratory virus vaccines. He obtained his MD from Northwestern University Medical School and trained in Pediatrics and Pediatric Infectious Diseases at the Stanford University School of Medicine.

Clinical Dx Showcase: Karius
Karius is a life sciences company focused on transforming infectious disease diagnosis through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing. The company’s genomics platform and clinically-curated pathogen database deliver unprecedented insight into the microbial landscape, providing clinicians with a comprehensive, quantitative test capable of identifying more than a thousand pathogens directly from blood and helping industry accelerate drug development.

Liquid Biopsy for Infectious Diseases – Clinical Applications of the Karius NGS Test
Discover precision medicine approaches in infectious disease using a novel next-generation sequencing-based method for pathogen detection from plasma. Hear clinical applications in liquid biopsy for infectious disease diagnosis with genomics, including cases related to invasive fungal infections, endocarditis, pneumonia and pediatric immunocompromised patients.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.